Residency · Residency · Geriatrics

Malnutrition and Sarcopenia

Introduction

Malnutrition and sarcopenia represent two of the most consequential yet underdiagnosed conditions in geriatric medicine, each independently associated with adverse outcomes and synergistically amplifying the other when both are present. Malnutrition affects 15 to 50 percent of hospitalized elderly patients, 5 to 10 percent of community-dwelling older adults, and 30 to 60 percent of long-term care residents, making it one of the most prevalent conditions in geriatric populations across all care settings. Sarcopenia, defined as the age-related loss of skeletal muscle mass and function, affects 10 to 27 percent of community-dwelling elderly and rises to approximately 50 percent prevalence in those aged 80 and older.

The relationship between malnutrition and sarcopenia is fundamentally synergistic: inadequate protein and caloric intake accelerates the loss of muscle mass, while the loss of muscle mass impairs functional recovery, reduces metabolic reserve, and further compromises nutritional status. Both conditions are independently associated with falls, fractures, disability, prolonged hospitalization, increased mortality, and impaired quality of life. Despite their high prevalence and profound clinical impact, both malnutrition and sarcopenia remain underdiagnosed and undertreated in routine clinical practice, representing a significant opportunity for geriatric intervention.

Malnutrition in Older Adults

Definition and Diagnostic Criteria

The Global Leadership Initiative on Malnutrition (GLIM) criteria, published in 2019, provide an internationally accepted framework for diagnosing malnutrition. The GLIM approach requires the presence of at least one phenotypic criterion combined with at least one etiologic criterion. The phenotypic criteria include unintentional weight loss (greater than 5 percent within six months or greater than 10 percent beyond six months), low body mass index (below 20 kg/m-squared in patients younger than 70 years or below 22 kg/m-squared in those aged 70 and older), and reduced muscle mass as measured by validated body composition methods. The etiologic criteria encompass reduced food intake or assimilation (defined as less than 50 percent of requirements for more than one week or any reduction sustained for more than two weeks) and disease burden or inflammation as evidenced by acute illness or chronic disease states. Severity is classified as moderate or severe based on the degree of weight loss, the extent of BMI reduction, and the magnitude of muscle mass loss.

Risk Factors and Causes

The causes of malnutrition in older adults are multifactorial and span physiological, medical, pharmacological, functional, cognitive, psychosocial, and oral health domains. Physiological changes of aging include the anorexia of aging, characterized by a reduced appetite drive, decreased taste and smell acuity, early satiety related to altered gut hormone signaling, delayed gastric emptying, and reduced thirst perception that predisposes to dehydration. Medical conditions contributing to malnutrition include dysphagia, poor dentition or edentulism, malabsorption syndromes, cancer, chronic obstructive pulmonary disease, heart failure, renal disease, chronic infections, and depression.

Medications frequently contribute to malnutrition through multiple mechanisms: anorexia may be caused by metformin, selective serotonin reuptake inhibitors, digoxin, and theophylline; nausea limits oral intake; dysgeusia (taste distortion) is a known side effect of angiotensin-converting enzyme inhibitors and metronidazole; and dry mouth from anticholinergic medications impairs the ability to chew and swallow comfortably. Functional limitations including the inability to shop for groceries, prepare food, or self-feed due to limited hand dexterity further compound the problem. Cognitive impairment, particularly in dementia, leads to forgetting to eat, inability to recognize food, and apraxia of eating. Psychosocial factors including loneliness, poverty, food insecurity, bereavement, social isolation, and institutionalization all reduce nutritional intake. Oral health problems such as xerostomia, ill-fitting dentures, oral pain, and candidiasis create direct barriers to adequate food consumption.

Screening Tools

The Mini Nutritional Assessment (MNA) is considered the gold standard screening tool for geriatric malnutrition. The MNA Short Form (MNA-SF) comprises six items yielding a score from 0 to 14, with scores of 7 or below indicating malnutrition, scores of 8 to 11 indicating risk, and scores of 12 to 14 indicating normal nutritional status. When the MNA-SF score is 11 or below, the full MNA with 18 items should be administered for comprehensive assessment. The Malnutrition Universal Screening Tool (MUST) incorporates BMI, weight loss history, and acute disease effect, and has been validated across multiple healthcare settings. The Nutritional Risk Screening 2002 (NRS-2002) is recommended by the European Society for Clinical Nutrition and Metabolism (ESPEN) specifically for hospitalized patients. The Simplified Nutritional Appetite Questionnaire (SNAQ) uses just four items and identifies significant risk of weight loss when the score is 14 or below.

Assessment

Comprehensive nutritional assessment encompasses anthropometric measurements, dietary evaluation, physical examination, laboratory studies, and functional measures. Anthropometric assessment includes weight, height, BMI, weight trend over a six-month trajectory, and calf circumference, with values below 31 cm suggesting sarcopenia. Dietary assessment employs 24-hour recall, food frequency questionnaires, and calorie counts to quantify actual intake relative to requirements.

Physical examination findings suggestive of malnutrition include temporal wasting, loss of subcutaneous fat over the triceps and orbital region, muscle wasting particularly of the quadriceps and interossei, edema, and changes in skin, hair, and nail quality. Laboratory assessment must be interpreted with caution. Albumin, with a half-life of 21 days, reflects inflammation and disease severity far more reliably than nutritional status; an albumin level below 3.5 g/dL is associated with increased morbidity and mortality but is not a reliable marker of nutritional status in acute illness. Prealbumin, with a half-life of 2 days, is more responsive to nutritional changes. C-reactive protein should be measured concurrently to interpret the degree of inflammatory confounding. Functional measures including grip strength, gait speed, and the Short Physical Performance Battery provide additional context for the assessment.

<image>A comprehensive infographic on malnutrition screening and assessment in older adults. Show a central figure of an elderly patient with radiating assessment domains. TOP: Screening tools — display the MNA-SF with its 6 items and scoring interpretation (traffic light: green 12-14, yellow 8-11, red ≤7). LEFT: Physical examination findings — labeled arrows pointing to temporal wasting, sunken cheeks, prominent clavicles, loose-fitting clothes, interosseous muscle wasting in hands, reduced calf circumference. RIGHT: Laboratory markers — show albumin (with note "reflects inflammation, not nutrition"), prealbumin (more responsive), CRP, vitamin deficiency panel. BOTTOM: Risk factors organized as a wheel with segments for physiological (anorexia of aging), medical (dysphagia, poor dentition), medications, functional (unable to cook), cognitive (dementia), and psychosocial (isolation, poverty). Include anthropometric measurements with cut-off values: BMI <22, calf circumference <31 cm, unintentional weight loss >5% in 6 months.</image>

Management of Malnutrition

Dietary Interventions

Caloric targets for malnourished elderly patients are 25 to 30 kcal/kg/day under baseline conditions, increasing to 30 to 35 kcal/kg/day during acute illness and wound healing. Protein targets are 1.0 to 1.2 g/kg/day for healthy elderly and 1.2 to 1.5 g/kg/day for malnourished or sarcopenic patients. Meal modifications should emphasize nutrient-dense foods over a volume-based approach, as elderly patients often cannot consume large volumes. Small, frequent meals served six times per day rather than three large meals improve total intake. Fortification strategies include adding protein powder, nut butters, cheese, cream, and olive oil to existing meals to increase caloric and protein density without increasing volume.

An important principle in geriatric nutrition is the liberalization of restrictive diets. Therapeutic diets such as low-salt, low-fat, and diabetic diets often reduce food intake more than they provide clinical benefit in elderly patients, and dietary restrictions should be individualized based on goals of care rather than applied reflexively. Oral nutritional supplements (ONS), typically providing 250 to 350 kcal and 15 to 20 grams of protein per serving, should be prescribed one to two times daily. Meta-analyses, including work by Stratton and colleagues, have demonstrated that ONS reduce mortality by 24 percent in malnourished hospitalized elderly. Supplements should be given between meals rather than as meal replacements, and compliance can be improved by offering a variety of flavors, serving supplements cold, and providing small volumes.

Enteral Nutrition

Enteral nutrition is indicated when oral intake is inadequate, the patient has a functioning gastrointestinal tract, and the treatment aligns with the patient's goals of care. Nasogastric tubes are appropriate for short-term use of less than four weeks, while percutaneous endoscopic gastrostomy (PEG) or percutaneous endoscopic jejunostomy (PEJ) tubes are considered when enteral feeding is anticipated for longer than four weeks.

The evidence regarding PEG tubes in advanced dementia is unequivocal and represents one of the most important clinical pearls in geriatric medicine. Cochrane reviews and the American Geriatrics Society position statement have demonstrated that PEG tubes in advanced dementia do not prevent aspiration pneumonia, do not improve survival, and do not improve functional outcomes. Furthermore, PEG tube placement is associated with significant complications including aspiration, tube displacement, insertion site infection, and the use of physical restraints to prevent tube removal. Careful hand feeding is the preferred alternative, as it provides comfort, social interaction, and outcomes that are similar to or better than tube feeding in this population.

Parenteral Nutrition

Parenteral nutrition is rarely indicated in geriatric patients and should be reserved for situations involving a non-functional gastrointestinal tract with a reversible underlying condition. It is associated with significant complications including line infections, metabolic derangements, and refeeding syndrome.

Address Modifiable Factors

A comprehensive approach to malnutrition management must address modifiable contributing factors. Dental care including denture fitting and dental treatment can dramatically improve oral intake. Dysphagia management requires speech-language pathology evaluation and may include texture-modified diets and thickened liquids guided by the International Dysphagia Diet Standardisation Initiative (IDDSI) framework. Depression treatment with SSRIs may be necessary, though these agents may initially suppress appetite. Medication review should identify and, where possible, discontinue appetite-suppressing drugs. Social interventions including congregate meals, Meals on Wheels, and caregiver meal preparation assistance address psychosocial barriers to adequate intake.

Appetite stimulants have limited evidence in elderly populations. Mirtazapine at 7.5 to 15 mg is a useful option when depression coexists, as it promotes both appetite and weight gain. Megestrol acetate is not recommended in elderly patients due to increased thromboembolic events, adrenal suppression, and mortality. Dronabinol has limited evidence and may cause confusion in elderly patients.

Sarcopenia

Definition (EWGSOP2, 2019)

The European Working Group on Sarcopenia in Older People revised their diagnostic criteria in 2019 (EWGSOP2), distinguishing primary sarcopenia, which is age-related with no other specific identifiable cause, from secondary sarcopenia, which is related to disease processes (cachexia, systemic inflammation), inactivity (bed rest, deconditioning), or inadequate nutrition. The diagnostic algorithm follows a three-tiered approach. Probable sarcopenia is identified by low muscle strength, defined as grip strength below 27 kg in men or below 16 kg in women, or a chair stand time exceeding 15 seconds for five repetitions. Confirmed sarcopenia requires low muscle strength combined with low muscle quantity or quality, measured by dual-energy X-ray absorptiometry (DXA) showing appendicular lean mass per height-squared below 7.0 kg/m-squared in men or below 5.5 kg/m-squared in women, or equivalent bioelectrical impedance analysis values. Severe sarcopenia is diagnosed when low strength, low muscle mass, and low physical performance coexist, with physical performance defined by gait speed below 0.8 m/s, Short Physical Performance Battery score of 8 or below, or Timed Up and Go of 20 seconds or greater.

Pathophysiology

The pathophysiology of sarcopenia is multifactorial, involving interconnected changes at the neurological, hormonal, inflammatory, mitochondrial, and cellular levels. Loss of motor neurons, particularly affecting fast-twitch type II fibers, reduces the number of functional motor units and shifts the muscle fiber composition toward slower, less powerful type I fibers. Hormonal changes including decreased testosterone, growth hormone, insulin-like growth factor-1, and vitamin D, combined with increased cortisol and myostatin, create a catabolic hormonal milieu. Chronic low-grade inflammation, mediated by interleukin-6 and tumor necrosis factor-alpha, activates muscle proteolysis through the ubiquitin-proteasome pathway. Mitochondrial dysfunction in skeletal muscle reduces energy production and increases oxidative stress.

A critically important concept is anabolic resistance, the blunted muscle protein synthesis response to both protein intake and exercise that characterizes aging muscle. Elderly adults require approximately 40 percent more leucine per meal to achieve the same anabolic response as younger adults, a finding with direct implications for dietary recommendations. Reduced satellite cell (muscle stem cell) function impairs the capacity for muscle repair and regeneration. Physical inactivity dramatically accelerates muscle loss: bed rest causes 1 to 5 percent muscle mass loss per day in elderly patients, with ten days of bed rest resulting in approximately 1 kg of lean mass loss.

Screening

The SARC-F questionnaire is the most widely used screening tool for sarcopenia, comprising five items assessing strength, assistance with walking, rising from a chair, climbing stairs, and falls history. A score of 4 or greater suggests sarcopenia. The SARC-F has low sensitivity (21 to 55 percent) but high specificity (90 to 98 percent), making it better at ruling in sarcopenia than ruling it out. Calf circumference below 31 cm is a simple, validated screening measure for low muscle mass. The SARC-CalF, which combines the SARC-F questionnaire with calf circumference measurement, offers improved sensitivity over either measure alone.

Management

Exercise — Most Effective Intervention

Resistance training is the cornerstone of sarcopenia management and represents the single most effective intervention available. Progressive resistance exercise (PRE) should be performed two to three sessions per week, with two to three sets of 8 to 12 repetitions per exercise, at an intensity of 60 to 80 percent of one-repetition maximum with progressive overload. Target muscle groups should include the quadriceps, hamstrings, hip extensors, and gluteals, as these large muscle groups are most critical for functional independence. Meta-analyses demonstrate that progressive resistance exercise increases muscle strength by 25 to 30 percent and muscle mass by 1 to 2 kg over 12 to 24 weeks.

The landmark study by Fiatarone and colleagues, published in the New England Journal of Medicine in 1994, demonstrated that even nursing home residents aged 72 to 98 years increased strength by 113 percent and gait speed by 12 percent with just 10 weeks of high-intensity progressive resistance exercise, establishing definitively that resistance training is effective at any age. Aerobic exercise complements resistance training by improving cardiovascular fitness, mitochondrial function, and insulin sensitivity in muscle. Combined multicomponent exercise incorporating resistance, aerobic, and balance training is the optimal approach. For hospitalized elderly patients, bed rest countermeasures including early mobilization protocols and resistance exercises performed in bed or chair are essential to mitigate the rapid muscle loss that accompanies immobility.

Nutritional Interventions

Protein intake of 1.2 to 1.5 g/kg/day, distributed evenly across three meals at 25 to 40 grams per meal, is recommended for sarcopenic elderly. The per-meal protein threshold is a critical concept: at least 25 to 30 grams of protein per meal is needed to optimally stimulate muscle protein synthesis in elderly adults due to anabolic resistance. Leucine supplementation of 2.5 to 3 grams per meal enhances mechanistic target of rapamycin (mTOR) signaling and muscle protein synthesis. Whey protein is the most rapidly absorbed protein source and is particularly leucine-rich, with approximately 13 percent leucine content by weight, making it an ideal supplement for elderly patients. Timing of protein intake within two hours of exercise maximizes muscle protein synthesis.

Vitamin D should be supplemented if levels are below 30 ng/mL, at doses of 800 to 2000 IU daily. Meta-analyses suggest that vitamin D alone has a modest effect on muscle function, but the combination with exercise is more effective. Creatine supplementation at 3 to 5 g/day has evidence for enhancing resistance training outcomes in elderly patients; a 2017 meta-analysis by Chilibeck and colleagues demonstrated an additional 1.37 kg lean mass gain and 3.25 kg leg press strength increase over controls performing exercise alone. Beta-hydroxy beta-methylbutyrate (HMB), a leucine metabolite, at 3 g/day may attenuate muscle loss during bed rest, though evidence is mixed for community-dwelling elderly. Omega-3 fatty acids at 2 to 4 g/day of EPA plus DHA may enhance the muscle protein synthesis response to protein feeding and provide anti-inflammatory effects.

Pharmacological Interventions

No FDA-approved pharmacotherapy currently exists specifically for sarcopenia, though several agents are under investigation. Testosterone increases lean mass and strength in hypogonadal men, and cardiovascular safety has been improved per the TRAVERSE trial, which demonstrated no increased risk of major adverse cardiovascular events. The role of testosterone in sarcopenia management is evolving. Selective androgen receptor modulators (SARMs) such as enobosarm have shown increases in lean mass in phase 2 trials, but regulatory challenges remain. Myostatin inhibitors, including bimagrumab (an anti-activin type II receptor antibody), increase lean mass by approximately 5 percent, though functional benefits have been inconsistent in clinical trials. GLP-1 receptor agonists raise concern about accelerating sarcopenia through their weight-loss effects, and body composition should be monitored when these agents are used for obesity, with resistance training combined as a protective measure.

<image>A diagnostic and management pathway for sarcopenia based on the EWGSOP2 algorithm. Start with "Suspect sarcopenia" (clinical suspicion, SARC-F ≥4, calf circumference <31 cm). Step 1: Assess muscle strength — grip strength (cut-offs: <27 kg men, <16 kg women) or chair stand test (>15 seconds for 5 stands). If low: "Probable sarcopenia — initiate interventions." Step 2: Confirm with muscle quantity measurement — DXA (ALMI <7.0 men, <5.5 women) or BIA. If low: "Confirmed sarcopenia." Step 3: Assess physical performance — gait speed, SPPB, TUG. If low: "Severe sarcopenia." Show intervention boxes at each stage: all stages get exercise (resistance training with specific prescription details) and nutrition (protein 1.2-1.5 g/kg/day, leucine 2.5-3g/meal, vitamin D). Severe sarcopenia adds multidisciplinary assessment and consideration of investigational therapies. Include a side panel showing the SARC-F questionnaire items with scoring. Use traffic light coloring: yellow for probable, orange for confirmed, red for severe.</image>

Cachexia vs. Sarcopenia vs. Malnutrition

Distinguishing among malnutrition, sarcopenia, and cachexia is clinically important because each has different pathophysiology, prognosis, and treatment implications, despite significant overlap. Malnutrition is fundamentally an inadequacy of nutrient intake relative to requirements and is potentially reversible with appropriate nutritional support. Sarcopenia is an age-related loss of muscle mass and function driven by multifactorial mechanisms, for which exercise is the primary intervention. Cachexia is a metabolic syndrome associated with an underlying illness such as cancer, congestive heart failure, chronic obstructive pulmonary disease, or chronic kidney disease, characterized by involuntary weight loss with muscle wasting driven by systemic inflammation; it is often refractory to nutritional supplementation alone.

The diagnostic criteria for cachexia include weight loss exceeding 5 percent over 12 months in the presence of an underlying disease, combined with at least three of the following: decreased muscle strength, fatigue, anorexia, low fat-free mass index, and abnormal biochemistry including elevated C-reactive protein or interleukin-6, anemia, or low albumin. It is important to recognize that overlap among these three conditions is common, and a single patient may have all three simultaneously, requiring a comprehensive and individualized management approach.

Key Clinical Pearls

• Screen all elderly patients for malnutrition at every encounter using validated tools (MNA-SF) — malnutrition is missed in 50-70% of cases
• Albumin is a marker of inflammation and disease severity, NOT a reliable marker of nutritional status — stop using it as a "nutrition lab"
• PEG tubes do NOT benefit patients with advanced dementia — careful hand feeding is preferred and provides equivalent outcomes with less harm
• Liberalize restrictive diets in frail elderly — a "heart-healthy" or "diabetic" diet that results in weight loss and malnutrition is worse than a palatable, calorie-dense diet
• Resistance training is effective for sarcopenia at ANY age — even 90+ year olds in nursing homes gain significant strength with progressive resistance exercise
• Protein distribution matters — aim for ≥25-30g per meal across 3 meals rather than one large protein load; include leucine-rich sources
• Anabolic resistance in aging means elderly adults need MORE protein and MORE leucine per meal than younger adults to achieve the same muscle protein synthesis response

References

1. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis (EWGSOP2). Age Ageing. 2019;48(1):16-31.
2. Cederholm T, Jensen GL, Correia MITD, et al. GLIM criteria for the diagnosis of malnutrition — a consensus report from the global clinical nutrition community. Clin Nutr. 2019;38(1):1-9.
3. Fiatarone MA, O'Neill EF, Ryan ND, et al. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med. 1994;330(25):1769-1775.
4. Volkert D, Beck AM, Cederholm T, et al. ESPEN guideline on clinical nutrition and hydration in geriatrics. Clin Nutr. 2019;38(1):10-47.
5. American Geriatrics Society Ethics Committee and Clinical Practice and Models of Care Committee. American Geriatrics Society feeding tubes in advanced dementia position statement. J Am Geriatr Soc. 2014;62(8):1590-1593.

Read this lecture as Markdown